ハイコンテントスクリーニングの世界市場：製品・サービス別、用途別、エンドユーザー別、地域別 - 2030年までの予測

世界のハイコンテントスクリーニングの市場規模は、2025年の15億2,000万米ドルから2030年には21億9,000万米ドルに達すると予測され、CAGRは7.5%と著しいものになるとみられています。

同市場は、高解像度イメージング、自動化、人工知能（AI）を活用したデータ解析の革新により、HCSワークフローの効率と精度が大幅に向上したため、著しいCAGRで成長しています。高速蛍光顕微鏡、共焦点イメージング、リアルタイムのライブセル解析を備えた高度な装置は、より深い細胞洞察を可能にし、創薬、毒性スクリーニング、疾患研究に不可欠なものとなっています。

製品・サービス別に見ると、ハイコンテントスクリーニング市場は、機器、消耗品・アクセサリー、ソフトウェア、サービスに分けられます。機器セグメントはさらに、ハイコンテンツイメージングプラットフォーム、細胞検出・分析システム、細胞イメージングシステムに分けられます。製薬やバイオテクノロジー研究において、ハイスループットスクリーニングやマルチプレックスアッセイの需要が高まっていることから、次世代HCSシステムの導入が加速しています。研究機関や商業研究所が生産性と効率の向上を目指す中、最先端のHCS装置への需要が市場の大幅な成長を牽引すると予想されます。

用途別セグメントは、創薬・開発、毒性学、基礎研究に分けられます。創薬・開発応用分野はさらに、一次スクリーニングと二次スクリーニング、標的同定とバリデーション、化合物プロファイリング、その他の創薬・開発応用分野に分けられます。創薬・開発が市場を独占したのは、創薬ワークフローにおける人工知能と自動化の統合がHCSの効率をさらに高め、前臨床研究に関連する時間とコストを削減するためです。さらに、規制機関は早期の毒性評価を重視しているため、臨床試験前の医薬品安全性評価にHCSが選ばれています。これらの要因が相まって、HCS市場では創薬・開発用途が圧倒的なシェアを占めています。

エンドユーザー別では、市場は製薬・バイオテクノロジー企業、学術・政府機関、CRO・CDMOに区分されます。2024年には製薬・バイオテクノロジー企業がこのセグメントを支配します。ハイコンテントスクリーニング（HCS）市場における製薬・バイオテクノロジー企業の高いシェアは、主に創薬と市場開拓におけるHCS技術の広範な利用によるものです。これらの企業は、安全性と有効性を確保しながら医薬品開発プロセスを加速するために、ハイスループットスクリーニング、リード化合物の最適化、毒性評価にHCSを活用しています。

市場は地域別に北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカに区分されます。北米は2024年にハイコンテントスクリーニング市場を独占し、予測期間中も支配が続くと予測されます。米国は、主要な学術研究機関の存在とバイオテクノロジーへの多額の投資により、北米市場をリードしています。同国は革新的な医学研究、個別化ヘルスケア、精密医療に注力しており、同市場における同国のリーダーシップをさらに後押ししています。欧州のハイコンテントスクリーニング市場は、特にドイツ、英国、フランスのような国々での研究開発活動の増加に支えられ、着実な成長を遂げています。

当レポートでは、世界のハイコンテントスクリーニング市場について調査し、製品・サービス別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

• イントロダクション
• 市場力学
• 顧客のビジネスに影響を与える動向/混乱
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• エコシステム分析
• AI/生成AIの影響
• 技術分析
• 特許分析
• 2025年～2026年の主な会議とイベント
• 規制状況
• ポーターのファイブフォース分析
• 主要な利害関係者と購入基準
• 投資と資金調達のシナリオ

第6章 ハイコンテントスクリーニング市場、製品・サービス別、2022年～2029年（100万米ドル）

• イントロダクション
• 機器
• 消耗品・アクセサリー
• ソフトウェア

第7章 ハイコンテントスクリーニング市場、用途別、2022年～2029年（100万米ドル）

• イントロダクション
• 創薬・開発
• 毒物
• 基礎研究

第8章 ハイコンテントスクリーニング市場、エンドユーザー別、2022年～2029年（100万米ドル）

• イントロダクション
• 製薬会社・バイオテクノロジー企業
• 学術機関・政府機関
• CRO・CDMO

第9章 ハイコンテントスクリーニング市場、地域別、2022年～2029年（100万米ドル）

• イントロダクション
• 北米
  • 北米のマクロ経済見通し
  • 米国
  • カナダ
• 欧州
  • 欧州のマクロ経済見通し
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • アジア太平洋のマクロ経済見通し
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • その他
• ラテンアメリカ
  • ラテンアメリカのマクロ経済見通し
  • ブラジル
  • その他
• 中東
  • 中東のマクロ経済見通し
  • GCC諸国
  • アラブ首長国連邦（UAE）
  • サウジアラビア王国（KSA）
  • その他中東
• アフリカ
  • アフリカのマクロ経済見通し

第10章 競合情勢

• イントロダクション
• 主要参入企業の戦略/強み
• 収益シェア分析（上位4～5社）
• 市場シェア分析（上位4～5社）
• 企業評価マトリックス：主要参入企業
• 企業評価マトリックス：スタートアップ/中小企業、2023年
• 競合シナリオ
• ブランド/製品比較分析
• 残留DNA検査市場におけるベンダー評価と財務指標

第11章 企業プロファイル

• 主要参入企業
  • DANAHER CORPORATION
  • REVVITY
  • BD
  • THERMO FISHER SCIENTIFIC INC.
  • AGILENT TECHNOLOGIES
  • MERCK KGAA
  • BIO-RAD LABORATORIES, INC.
  • NIKON INSTRUMENTS INC.
  • CARL ZEISS AG
  • SARTORIUS AG
  • YOKOGAWA ELECTRIC CORPORATION
  • TECAN TRADING AG
  • CORNING INCORPORATED
  • CHARLES RIVER LABORATORIES
• その他の企業
  • EVIDENT
  • PROMEGA CORPORATION
  • CREATIVE BIOLABS
  • SYSMEX CORPORATION
  • ENZO LIFE SCIENCES
  • STRATEDIGM CORPORATION
  • AKOYA BIOSCIENCES
  • SPHERE FLUIDICS
  • CREATIVE BIOSTRUCTURE
  • CREATIVE BIOARRAY
  • CELL SIGNALLING TECHNOLOGY
  • STANDARD BIOTOOLS
  • ARACELI BIOSCIENCES

第12章 付録

List of Tables

• TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
• TABLE 2 HIGH-CONTENT SCREENING MARKET: RISK ANALYSIS
• TABLE 3 AVERAGE SELLING PRICE TREND OF HIGH-CONTENT SCREENING PRODUCTS, BY KEY PLAYER, 2022-2024
• TABLE 4 AVERAGE SELLING PRICE TREND OF HIGH-CONTENT SCREENING PRODUCTS, BY REGION, 2022-2024
• TABLE 5 IMPORT DATA FOR HS CODE 901190, 2019-2023 (USD)
• TABLE 6 EXPORT DATA FOR HS CODE 901190, 2019-2023 (USD)
• TABLE 7 HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 8 HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 9 HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 10 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 11 EUROPE: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 12 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 13 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 14 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 15 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 16 HIGH-CONTENT IMAGING PLATFORMS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 17 NORTH AMERICA: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 18 EUROPE: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 19 HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 20 LATIN AMERICA: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 21 MIDDLE EAST: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 22 GCC COUNTRIES: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 23 GCC COUNTRIES: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 24 NORTH AMERICA: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 25 EUROPE: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 26 ASIA PACIFIC: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 27 LATIN AMERICA: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 28 MIDDLE EAST: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 29 GCC COUNTRIES: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 30 CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 31 NORTH AMERICA: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 32 EUROPE: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 33 ASIA PACIFIC: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 34 LATIN AMERICA: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 35 MIDDLE EAST: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 36 GCC COUNTRIES: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 37 HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 38 HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 39 NORTH AMERICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 40 EUROPE: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 41 ASIA PACIFIC: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 42 LATIN AMERICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 43 MIDDLE EAST: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 44 GCC COUNTRIES: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 45 REAGENTS & ASSAY KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 46 NORTH AMERICA: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 47 EUROPE: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 48 ASIA PACIFIC: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 49 LATIN AMERICA: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 50 MIDDLE EAST: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 51 GCC COUNTRIES: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 52 MICROPLATES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 53 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 54 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 55 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 56 LATIN AMERICA: MICROPLATES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 57 MIDDLE EAST: MICROPLATES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 58 GCC COUNTRIES: MICROPLATES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 59 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 60 NORTH AMERICA: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 61 EUROPE: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 62 ASIA PACIFIC: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 63 LATIN AMERICA: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 64 MIDDLE EAST: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 65 GCC COUNTRIES: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 66 HIGH-CONTENT SCREENING SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 67 NORTH AMERICA: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 68 EUROPE: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 69 ASIA PACIFIC: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 70 LATIN AMERICA: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 71 MIDDLE EAST: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 72 GCC COUNTRIES: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 73 HIGH-CONTENT SCREENING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 74 NORTH AMERICA: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 75 EUROPE: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 76 ASIA PACIFIC: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 77 LATIN AMERICA: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 78 MIDDLE EAST: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 79 GCC COUNTRIES: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 80 HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 81 HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 82 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 83 EUROPE: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 84 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 85 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 86 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 87 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 88 HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 89 HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 90 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 91 EUROPE: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 92 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 93 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 94 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 95 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 96 HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 97 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 98 EUROPE: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 99 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 100 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 101 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 102 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 103 HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 104 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 105 EUROPE: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 106 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 107 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 108 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 109 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 110 HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 111 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 112 EUROPE: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 113 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 114 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 115 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 116 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 117 HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 118 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 119 EUROPE: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 120 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 121 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 122 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 123 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 124 HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 125 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 126 EUROPE: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 127 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 128 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 129 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 130 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 131 HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 132 HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 133 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 134 EUROPE: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 135 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 136 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 137 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 138 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 139 HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 140 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 141 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 142 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 143 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 144 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 145 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 146 HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 147 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 148 EUROPE: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 149 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 150 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 151 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 152 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 153 HIGH-CONTENT SCREENING MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 154 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 155 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 156 NORTH AMERICA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 157 NORTH AMERICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 158 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 159 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 160 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 161 US: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 162 US: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 163 US: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 164 US: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 165 US: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 166 US: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 167 CANADA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 168 CANADA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 169 CANADA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 170 CANADA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 171 CANADA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 172 CANADA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 173 EUROPE: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 174 EUROPE: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 175 EUROPE: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 176 EUROPE: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 177 EUROPE: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 178 EUROPE: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 179 EUROPE: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 180 EUROPE: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 181 GERMANY: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 182 GERMANY: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 183 GERMANY: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 184 GERMANY: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 185 GERMANY: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 186 UK: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 187 UK: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 188 UK: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 189 UK: HIGH-CONTENT SCREENING MARKET, BY application, 2023-2030 (USD MILLION)
• TABLE 190 UK: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 191 UK: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 192 FRANCE: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 193 FRANCE: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 194 FRANCE: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 195 FRANCE: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION
• TABLE
• TABLE 196 FRANCE: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 197 FRANCE: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 198 ITALY: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 199 ITALY: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 200 ITALY: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 201 ITALY: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 202 ITALY: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 203 ITALY: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 204 SPAIN: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 205 SPAIN: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 206 SPAIN: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 207 SPAIN: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 208 SPAIN: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 209 SPAIN: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION
• TABLE 210 REST OF EUROPE: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 211 REST OF EUROPE: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 212 REST OF EUROPE: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 213 REST OF EUROPE: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 214 REST OF EUROPE: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 215 REST OF EUROPE: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 216 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 217 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 218 ASIA PACIFIC: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 219 ASIA PACIFIC: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 220 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 221 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 222 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 223 CHINA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 224 CHINA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 225 CHINA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 226 CHINA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 227 CHINA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 228 CHINA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 229 JAPAN: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 230 JAPAN: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 231 JAPAN: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 232 JAPAN: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 233 JAPAN: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 234 JAPAN: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 235 INDIA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 236 INDIA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 237 INDIA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 238 INDIA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 239 INDIA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 240 INDIA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 241 SOUTH KOREA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 242 SOUTH KOREA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION
• TABLE 243 SOUTH KOREA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 244 SOUTH KOREA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 245 SOUTH KOREA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 246 SOUTH KOREA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 247 AUSTRALIA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 248 AUSTRALIA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 249 AUSTRALIA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 250 AUSTRALIA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 251 AUSTRALIA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 252 AUSTRALIA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 253 REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 254 REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 255 REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 256 REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 257 REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 258 REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 259 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 260 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 261 LATIN AMERICA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 262 LATIN AMERICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 263 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 264 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 265 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 266 BRAZIL: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 267 BRAZIL: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 268 BRAZIL: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 269 BRAZIL: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 270 BRAZIL: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 271 BRAZIL: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 272 MEXICO: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 273 MEXICO: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 274 MEXICO: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 275 MEXICO: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 276 MEXICO: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 277 MEXICO: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 278 REST OF LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 279 REST OF LATIN AMERICA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 280 REST OF LATIN AMERICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 281 REST OF LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 282 REST OF LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 283 REST OF LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 284 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 285 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 286 MIDDLE EAST: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 287 MIDDLE EAST: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 288 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 289 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 290 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 291 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 292 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 293 GCC COUNTRIES: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 294 GCC COUNTRIES: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 295 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 296 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 297 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 298 SAUDI ARABIA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 299 SAUDI ARABIA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 300 SAUDI ARABIA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION
• TABLE 301 SAUDI ARABIA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 302 SAUDI ARABIA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 303 SAUDI ARABIA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 304 UAE: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 305 UAE: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 306 UAE: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 307 UAE: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 308 UAE: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 309 UAE: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 310 REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 311 REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 312 REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 313 REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 314 REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 315 REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 316 REST OF MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 317 REST OF MIDDLE EAST: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 318 REST OF MIDDLE EAST: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 319 REST OF MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 320 REST OF MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 321 REST OF MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 322 AFRICA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
• TABLE 323 AFRICA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 324 AFRICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 325 AFRICA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 326 AFRICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 327 AFRICA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 328 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 329 DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-FEBRUARY 2025
• TABLE 330 REVVITY: PRODUCTS/SERVICES OFFERED
• TABLE 331 REVVITY: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-FEBRUARY 2025
• TABLE 332 BD: PRODUCTS /SERVICES OFFERED
• TABLE 333 BD: DEALS, JANUARY 2022-FEBRUARY 2025
• TABLE 334 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
• TABLE 335 AGILENT TECHNOLOGIES: PRODUCTS/SERVICES OFFERED
• TABLE 336 MERCK KGAA: PRODUCTS/SERVICES OFFERED
• TABLE 337 BIO-RAD LABORATORIES: PRODUCTS/SERVICES OFFERED
• TABLE 338 BIO-RAD LABORATORIES: DEALS, JANUARY 2022-FEBRUARY 2025
• TABLE 339 NIKON CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 340 NIKON CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-FEBRUARY 2025
• TABLE 341 NIKON CORPORATION: EXPANSIONS, JANUARY 2022-FEBRUARY 2025
• TABLE 342 CARL ZEISS AG: PRODUCTS/SERVICES OFFERED
• TABLE 343 CARL ZEISS AG: DEALS, JANUARY 2022-FEBRUARY 2025
• TABLE 344 SARTORIUS AG: PRODUCTS/SERVICES OFFERED
• TABLE 345 SARTORIUS AG: DEALS, JANUARY 2022-FEBRUARY 2025
• TABLE 346 YOKOGAWA ELECTRIC CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 347 YOKOGAWA ELECTRIC CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-FEBRUARY 2025
• TABLE 348 TECAN: PRODUCTS/SERVICES OFFERED
• TABLE 349 CORNING INCORPORATED: PRODUCTS/SERVICES OFFERED
• TABLE 350 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED
• TABLE 351 EVIDENT: PRODUCTS/SERVICES OFFERED
• TABLE 352 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 353 CREATIVE BIOLABS: PRODUCTS/SERVICES OFFERED
• TABLE 354 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 355 ENZO LIFE SCIENCES: PRODUCTS /SERVICES OFFERED
• TABLE 356 STRATEDIGM: PRODUCTS/SERVICES OFFERED
• TABLE 357 AKOYA BIOSCIENCES: PRODUCTS/SERVICES OFFERED
• TABLE 358 SPHERE FLUIDICS: PRODUCTS/SERVICES OFFERED
• TABLE 359 CREATIVE BIOSTRUCTURE: PRODUCTS/SERVICES OFFERED
• TABLE 360 CREATIVE BIOARRAY: PRODUCTS/SERVICES OFFERED
• TABLE 361 CELL SIGNALING TECHNOLOGY: PRODUCTS/SERVICES OFFERED
• TABLE 362 STANDARD BIOTOOLS: PRODUCTS/SERVICES OFFERED
• TABLE 363 ARACELI BIOSCIENCES: PRODUCTS/SERVICES OFFERED

List of Figures

• FIGURE 1 HIGH-CONTENT SCREENING MARKET SEGMENTATION AND REGIONAL SCOPE
• FIGURE 2 HIGH-CONTENT SCREENING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
• FIGURE 3 HIGH-CONTENT SCREENING MARKET SIZE ESTIMATION, 2024
• FIGURE 4 APPROACH 1: COMPANY REVENUE ANALYSIS-BASED MARKET ESTIMATION, 2024
• FIGURE 5 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS (2024)
• FIGURE 6 SEGMENTAL SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH (2024)
• FIGURE 7 HIGH-CONTENT SCREENING MARKET: CAGR PROJECTIONS
• FIGURE 8 HIGH-CONTENT SCREENING MARKET: CAGR PROJECTIONS
• FIGURE 9 HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2025-2030
• FIGURE 10 HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2025-2030
• FIGURE 11 HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2025-2030
• FIGURE 12 HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2025-2030
• FIGURE 13 HIGH-CONTENT SCREENING MARKET, BY END USER, 2025-2030
• FIGURE 14 HIGH-CONTENT SCREENING MARKET: GEOGRAPHIC ANALYSIS
• FIGURE 15 TECHNOLOGICAL ADVANCEMENTS IN HIGH-CONTENT SCREENING INSTRUMENTS TO DRIVE MARKET GROWTH
• FIGURE 16 INSTRUMENTS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2024
• FIGURE 17 CHINA LIKELY TO REGISTER HIGHEST GROWTH IN GLOBAL HIGH-CONTENT SCREENING MARKET OVER FORECAST PERIOD
• FIGURE 18 HIGH-CONTENT SCREENING MARKET, BY END USER, 2024
• FIGURE 19 AVERAGE SELLING PRICE TREND OF HIGH-CONTENT SCREENING PRODUCTS, BY KEY PLAYER, 2022-2024
• FIGURE 20 AVERAGE SELLING PRICE TREND OF HIGH-CONTENT SCREENING PRODUCTS, BY REGION, 2022-2024
• FIGURE 21 HIGH-CONTENT SCREENING MARKET: VALUE CHAIN ANALYSIS
• FIGURE 22 HIGH-CONTENT SCREENING MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 23 KEY BUYING CRITERIA FOR HCS PRODUCTS, BY END USER
• FIGURE 24 HIGH-CONTENT SCREENING MARKET: ECOSYSTEM ANALYSIS
• FIGURE 25 IMPACT OF AI ON HIGH-CONTENT SCREENING ECOSYSTEM
• FIGURE 26 HIGH-CONTENT SCREENING MARKET: INVESTMENT & FUNDING SCENARIO
• FIGURE 27 HIGH-CONTENT SCREENING MARKET: PATENT ANALYSIS, 2014-2024
• FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN HIGH-CONTENT SCREENING MARKET, 2020-2024
• FIGURE 29 HIGH-CONTENT SCREENING MARKET SHARE ANALYSIS, 2024
• FIGURE 30 EV/EBIDTA OF KEY VENDORS, 2025
• FIGURE 31 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025

The global high content screening market is anticipated to reach USD 2.19 billion in 2030 from USD 1.52 billion in 2025, with a significant CAGR of 7.5%. The market is growing at a significant CAGR owing to the innovations in high-resolution imaging, automation, and artificial intelligence (AI)-powered data analysis, which have significantly enhanced the efficiency and accuracy of HCS workflows. Advanced instruments equipped with high-speed fluorescence microscopy, confocal imaging, and real-time live-cell analysis enable deeper cellular insights, making them essential for drug discovery, toxicity screening, and disease research.

"Instruments dominated the products & service segment"

Based on product & service, the high content screening market is divided into instruments, consumables & accessories, software, and services. The instrument segment is further divided into high content imaging platforms, cell detection and analysis systems, and cell imaging systems. The rising demand for high-throughput screening and multiplexed assays in pharmaceutical and biotechnology research has accelerated the adoption of next-generation HCS systems. As research institutions and commercial laboratories seek to improve productivity and efficiency, the demand for cutting-edge HCS instruments is expected to drive significant market growth.

"Drug discovery & development application segment is anticipated to grow at a great pace"

The application segment is divided into drug discovery & development applications, toxicology, and basic research. The drug discovery & development application segment is further divided into primary screening and secondary screening, target identification and validation, compound profiling, and other drug discovery & development applications. The drug discovery & development dominated the market owing to the integration of artificial intelligence and automation in drug discovery workflows further enhances the efficiency of HCS, reducing time and costs associated with preclinical research. Furthermore, regulatory bodies emphasize early toxicity assessment, making HCS a preferred choice for evaluating drug safety before clinical trials. These factors collectively contribute to the dominant market share of drug discovery and development applications in the HCS market.

"Pharmaceutical & Biotechnology Companies dominated the segment"

Based on the end users, the market is segmented into pharmaceutical & biotechnology companies, academic & government institutes, and CROs & CDMOs. Pharmaceutical & biotechnology companies dominated the segment in 2024. The high share of pharmaceutical and biotechnology companies in the high content screening (HCS) market is primarily driven by their extensive use of HCS technologies in drug discovery and development. These companies rely on HCS for high-throughput screening, lead optimization, and toxicity assessment to accelerate the drug development process while ensuring safety and efficacy.

"North America: the largest share of the high content screening market"

The market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the high content screening market in 2024 and is estimated to continue dominance during the forecast period. US leads the North American market, driven by the presence of leading academic & research institutions, and significant investment in biotechnology. The country's focus on innovative medical research, personalized healthcare, and precision medicine further boosts its leadership in the market. European high content screening market is experiencing steady growth, supported by increasing research and development activities, especially in countries like Germany, the UK, and France.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the high content screening market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Tire 1- 55%, Tire 2-25%, Tire 3- 20%
• By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

The prominent players operating in the high content screening market are Danaher Corporation (US), Revvity, Inc. (US), BD (US), Carl Zeiss AG (Germany), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Corning Incorporated (US), Bio-Rad Laboratories Inc (US), Tecan Trading AG (Switzerland), Evident (Japan), Sysmex Corporation (Japan), Yokogawa Electric Corporation (Japan), Nikon Corporation (Japan), Sartorius AG (Germany), Promega Corporation (US), Creative Biolabs (US), Enzo Life Sciences (US), Stratedigm Inc. (US), Akoya Biosciences, Inc. (US), Sphere Fluidics (UK), Creative Biostructure (US), Creative Bioarray (US), Cell Signalling Technology (US), Standard Biotools (US), Araceli Biosciences (US), and among others.

Research Coverage:

High content screening market report is segmented based on products & services (instruments (high content imaging platforms, cell detection and analysis systems, and cell imaging systems), consumables & accessories (reagents & assay kits, microplates, and other consumables accessories), software, and services. Applications (drug discovery & development applications (primary screening and secondary screening, target identification and validation, compound profiling, and other drug discovery & development applications), toxicology, and basic research, end users (pharmaceutical & biotechnology companies, academic & government institutes, and CROs & CDMOs). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the high content screening market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the high content screening market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the high content screening and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Advancements in Imaging Technologies, Increased R&D projects, Adoption of High Throughput Screening, implementing organoid models in HCS), restraints (High Equipment and Reagents Costs, Complexity of Data Analysis), opportunities (Integration of AI and ML, Expansion into new applications) and Challenges (Lack of Standardized Protocol) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on upcoming technologies in high content screening, research and development activities, and new product launches in the high content screening market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high content screening market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players Danaher Corporation (US), Revvity, Inc. (US), BD (US), Carl Zeiss AG (Germany), Merck KGaA (Germany), and Thermo Fisher Scientific, Inc. (US), among others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 OBJECTIVES OF THE STUDY
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED FOR THE STUDY
• 1.4 CURRENCY USED FOR THE STUDY
• 1.5 LIMITATIONS
• 1.6 MARKET STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES
  • 1.7.1 IMPACT OF AI/GENERATIVE AI

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 INSIGHTS FROM PRIMARY
  • 2.2.2 SEGMENT ASSESSMENT METHODOLOGY
• 2.3 MARKET GROWTH RATE PROJECTIONS
• 2.4 DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
  • 5.2.2 RESTRAINTS
  • 5.2.3 OPPORTUNITIES
  • 5.2.4 CHALLENGES
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS BUSINESS
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
  • 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 IMPACT OF AI/GEN AI
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
  • 5.9.3 ADJACENT TECHNOLOGIES
• 5.10 PATENT ANALYSIS
• 5.11 KEY CONFERENCES & EVENTS 2025-2026
• 5.12 REGULATORY LANDSCAPE
  • 5.12.1 REGULATORY SCENARIO
  • 5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS
• 5.13 PORTER'S FIVE FORCES ANALYSIS
  • 5.13.1 THREAT OF NEW ENTRANTS
  • 5.13.2 THREAT OF SUBSTITUTE
  • 5.13.3 BARGAINING POWER OF SUPPLIERS
  • 5.13.4 BARGAINING POWER OF BUYERS
  • 5.13.5 INTENSITY OF COMPETITION RIVALRY
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
  • 5.14.2 BUYING CRITERIA FOR END USERS
• 5.15 INVESTMENT AND FUNDING SCENARIO

6 HIGH CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)

• 6.1 INTRODUCTION
• 6.2 INSTRUMENTS
  • 6.2.1 CELL IMAGING SYSTEMS
  • 6.2.2 CELL DETECTION AND ANALYSIS SYSTEMS
  • 6.2.3 HIGH CONTENT IMAGING PLATFORMS
• 6.3 CONSUMABLES & ACCESSORIES
  • 6.3.1 REAGENTS & ASSAY KITS
  • 6.3.2 MICROPLATES
  • 6.3.3 OTHER CONSUMABLES & ACCESSORIES
• 6.4 SOFTWARE
• 6.5 SERVICES Note 1: Other consumables & accessories segment is inclusive of cell culture accessories, microscopy accessories, and plate sealers. Note 2: The above product & service segmentation is subject to change during research.

7 HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

• 7.1 INTRODUCTION
• 7.2 DRUG DISCOVERY AND DEVELOPMENT
  • 7.2.1 TARGET IDENTIFICATION AND VALIDATION
  • 7.2.2 PRIMARY SCREENING AND SECONDARY SCREENING
  • 7.2.3 COMPOUND PROFILING
  • 7.2.4 OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS (IF ANY)
• 7.2 TOXICOLOGY
• 7.3 BASIC RESEARCH Note 3: Basic research application segment is inclusive of cancer cell line screening, epigenetics, gene expression analysis, and stem cell research.

8 HIGH CONTENT SCREENING MARKET, BY END USER, 2022-2029 (USD MILLION)

• 8.1 INTRODUCTION
• 8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
• 8.3 ACADEMIC AND GOVERNMENT INSTITUTES
• 8.4 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS

9 HIGH CONTENT SCREENING MARKET, BY REGION, 2022-2029 (USD MILLION)

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
  • 9.2.3 CANADA
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
  • 9.3.3 UK
  • 9.3.4 FRANCE
  • 9.3.5 ITALY
  • 9.3.6 SPAIN
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
  • 9.4.3 CHINA
  • 9.4.4 INDIA
  • 9.4.5 SOUTH KOREA
  • 9.4.6 AUSTRALIA
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
  • 9.5.3 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
  • 9.6.2 GCC COUNTRIES 9.6.2.1 UNITED ARAB EMIRATES (UAE) 9.6.2.2 KINGDOM OF SAUDI ARABIA (KSA) 9.6.2.3 REST OF GCC COUNTRIES
  • 12.6.3 REST OF MIDDLE EAST
• 9.7 AFRICA
  • 9.7.1 MACROECONOMIC OUTLOOK FOR AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYERS STRATEGIES/ RIGHT TO WIN
• 10.3 REVENUE SHARE ANALYSIS (TOP 4-5 PLAYERS)
• 10.4 MARKET SHARE ANALYSIS (TOP 4-5 PLAYERS)
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS
    • 10.5.5.1 COMPANY FOOTPRINT
    • 10.5.5.2 PRODUCT FOOTPRINT
    • 10.5.5.3 SERVICE FOOTPRINT
    • 10.5.5.4 APPLICATION FOOTPRINT
    • 10.5.5.5 REGION FOOTPRINT
• 10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 10.6.5.1 DETAILED LIST OF KEY STARTUPS/ SMES
    • 10.6.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/ SMES
• 10.7 COMPETITIVE SCENARIO
  • 10.7.1 DEALS
  • 10.7.2 OTHER DEVELOPMENTS
• 10.8 BRAND/ PRODUCT COMPARATIVE ANALYSIS
• 10.9 VENDOR VALUATION AND FINANCIAL METRICS OF THE RESIDUAL DNA TESTING MARKET

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 DANAHER CORPORATION
  • 11.1.2 REVVITY
  • 11.1.3 BD
  • 11.1.4 THERMO FISHER SCIENTIFIC INC.
  • 11.1.5 AGILENT TECHNOLOGIES
  • 11.1.6 MERCK KGAA
  • 11.1.7 BIO-RAD LABORATORIES, INC.
  • 11.1.8 NIKON INSTRUMENTS INC.
  • 11.1.9 CARL ZEISS AG
  • 11.1.10 SARTORIUS AG
  • 11.1.11 YOKOGAWA ELECTRIC CORPORATION
  • 11.1.12 TECAN TRADING AG
  • 11.1.13 CORNING INCORPORATED
  • 11.1.14 CHARLES RIVER LABORATORIES
• 11.2 OTHER PLAYERS
  • 11.2.1 EVIDENT
  • 11.2.2 PROMEGA CORPORATION
  • 11.2.3 CREATIVE BIOLABS
  • 11.2.4 SYSMEX CORPORATION
  • 11.2.5 ENZO LIFE SCIENCES
  • 11.2.6 STRATEDIGM CORPORATION
  • 11.2.7 AKOYA BIOSCIENCES
  • 11.2.8 SPHERE FLUIDICS
  • 11.2.9 CREATIVE BIOSTRUCTURE
  • 11.2.10 CREATIVE BIOARRAY
  • 11.2.11 CELL SIGNALLING TECHNOLOGY
  • 11.2.12 STANDARD BIOTOOLS
  • 11.2.13 ARACELI BIOSCIENCES

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
• 12.4 AVAILABLE CUSTOMIZATIONS
• 12.5 RELATED REPORTS
• 12.6 AUTHOR DETAILS